Remarkable response to anti-PD1 immunotherapy in refractory metastatic high-grade myxofibrosarcoma patient A case report

Luo, Y; Li, M; Zhou, Y; Tang, F; Lu, MX; Xie, HM; Wang, YT; Duan, H; Zhang, WL; Tu, CQ

Tu, CQ (corresponding author), Sichuan Univ, West China Hosp, Dept Orthoped, Chengdu 610041, Sichuan, Peoples R China.

MEDICINE, 2021; 100 (12):

Abstract

Introduction: Myxofibrosarcoma (MFS) is a locally aggressive tumor and has the potential to be fatal because of distant metastasis. Immunotherapy targ......

Full Text Link